These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26544583)

  • 1. Obesity is associated with greater inflammation and monocyte activation among HIV-infected adults receiving antiretroviral therapy.
    Conley LJ; Bush TJ; Rupert AW; Sereti I; Patel P; Brooks JT; Baker JV;
    AIDS; 2015 Oct; 29(16):2201-7. PubMed ID: 26544583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between inflammation, immune activation, and bone health among HIV-infected adults on stable antiretroviral therapy.
    Erlandson KM; OʼRiordan M; Labbato D; McComsey GA
    J Acquir Immune Defic Syndr; 2014 Mar; 65(3):290-8. PubMed ID: 24525466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The metabolic and cardiovascular consequences of obesity in persons with HIV on long-term antiretroviral therapy.
    Koethe JR; Grome H; Jenkins CA; Kalams SA; Sterling TR
    AIDS; 2016 Jan; 30(1):83-91. PubMed ID: 26418084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaemia is associated with monocyte activation in HIV-infected adults on antiretroviral therapy.
    Lipshultz HM; Hileman CO; Ahuja S; Funderburg NT; McComsey GA
    Antivir Ther; 2015; 20(5):521-7. PubMed ID: 25668820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection.
    Wilson EM; Singh A; Hullsiek KH; Gibson D; Henry WK; Lichtenstein K; Önen NF; Kojic E; Patel P; Brooks JT; Sereti I; Baker JV;
    J Infect Dis; 2014 Nov; 210(9):1396-406. PubMed ID: 24813472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cigarette Smoking and Inflammation, Monocyte Activation, and Coagulation in HIV-Infected Individuals Receiving Antiretroviral Therapy, Compared With Uninfected Individuals.
    Kooij KW; Wit FW; Booiman T; van der Valk M; Schim van der Loeff MF; Kootstra NA; Reiss P;
    J Infect Dis; 2016 Dec; 214(12):1817-1821. PubMed ID: 27683822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity.
    Bastard JP; Fellahi S; Couffignal C; Raffi F; Gras G; Hardel L; Sobel A; Leport C; Fardet L; Capeau J;
    J Antimicrob Chemother; 2015; 70(6):1816-24. PubMed ID: 25733587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central obesity is a contributor to systemic inflammation and monocyte activation in virally suppressed adults with chronic HIV in Kenya.
    Temu TM; Wagoner J; Masyuko S; O'Connor A; Zifodya JS; Macharia P; Wanjalla CN; Mogaka JN; Chohan B; Omodi VM; Gervassi AL; Oyugi J; Page ST; Farquhar C; Polyak SJ
    AIDS; 2021 Sep; 35(11):1723-1731. PubMed ID: 34033591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy.
    Hattab S; Guiguet M; Carcelain G; Fourati S; Guihot A; Autran B; Caby F; Marcelin AG; Costagliola D; Katlama C
    HIV Med; 2015 Oct; 16(9):553-62. PubMed ID: 25944318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidized lipoproteins are associated with markers of inflammation and immune activation in HIV-1 infection.
    Kelesidis T; Jackson N; McComsey GA; Wang X; Elashoff D; Dube MP; Brown TT; Yang OO; Stein JH; Currier JS
    AIDS; 2016 Nov; 30(17):2625-2633. PubMed ID: 27603288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy reduces but does not normalize immune and vascular inflammatory markers in adults with chronic HIV infection in Kenya.
    Temu TM; Zifodya JS; Polyak SJ; Wagoner J; Wanjalla CN; Masyuko S; Nyabiage J; Kinuthia J; Bloomfield GS; Page ST; Farquhar C
    AIDS; 2021 Jan; 35(1):45-51. PubMed ID: 33055570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.
    Sereti I; Krebs SJ; Phanuphak N; Fletcher JL; Slike B; Pinyakorn S; O'Connell RJ; Rupert A; Chomont N; Valcour V; Kim JH; Robb ML; Michael NL; Douek DC; Ananworanich J; Utay NS;
    Clin Infect Dis; 2017 Jan; 64(2):124-131. PubMed ID: 27737952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of initiation of antiretroviral therapy on monocyte, endothelial and platelet function in HIV-1 infection.
    O'Halloran JA; Dunne E; Gurwith M; Lambert JS; Sheehan GJ; Feeney ER; Pozniak A; Reiss P; Kenny D; Mallon P
    HIV Med; 2015 Nov; 16(10):608-19. PubMed ID: 26111187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection.
    Carrico AW; Cherenack EM; Roach ME; Riley ED; Oni O; Dilworth SE; Shoptaw S; Hunt P; Roy S; Pallikkuth S; Pahwa S
    AIDS; 2018 Mar; 32(6):767-771. PubMed ID: 29369159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated plasma soluble CD14 and skewed CD16+ monocyte distribution persist despite normalisation of soluble CD163 and CXCL10 by effective HIV therapy: a changing paradigm for routine HIV laboratory monitoring?
    Castley A; Berry C; French M; Fernandez S; Krueger R; Nolan D
    PLoS One; 2014; 9(12):e115226. PubMed ID: 25544986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune activation despite suppressive highly active antiretroviral therapy is associated with higher risk of viral blips in HIV-1-infected individuals.
    Zoufaly A; Kiepe JG; Hertling S; Hüfner A; Degen O; Feldt T; Schmiedel S; Kurowski M; van Lunzen J
    HIV Med; 2014 Sep; 15(8):449-57. PubMed ID: 24580846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy.
    Funderburg NT; Jiang Y; Debanne SM; Labbato D; Juchnowski S; Ferrari B; Clagett B; Robinson J; Lederman MM; McComsey GA
    J Acquir Immune Defic Syndr; 2015 Apr; 68(4):396-404. PubMed ID: 25514794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.
    Longenecker CT; Funderburg NT; Jiang Y; Debanne S; Storer N; Labbato DE; Lederman MM; McComsey GA
    HIV Med; 2013 Jul; 14(6):385-90. PubMed ID: 23332012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients.
    Bastard JP; Soulié C; Fellahi S; Haïm-Boukobza S; Simon A; Katlama C; Calvez V; Marcelin AG; Capeau J
    Antivir Ther; 2012; 17(5):915-9. PubMed ID: 22436412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-clinical carotid atherosclerosis and sCD163 among virally suppressed HIV patients in Botswana compared with uninfected controls.
    Mosepele M; Hemphill LC; Moloi W; Moyo S; Nkele I; Makhema J; Bennett K; Triant VA; Lockman S
    PLoS One; 2017; 12(6):e0179994. PubMed ID: 28662159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.